Immunological and Antitumor Effects of IL-23 as a Cancer Vaccine Adjuvant

The promising, but modest, clinical results of many human cancer vaccines indicate a need for vaccine adjuvants that can increase both the quantity and the quality of vaccine-induced, tumor-specific T cells. In this study we tested the immunological and antitumor effects of the proinflammatory cytok...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Overwijk, Willem W., de Visser, Karin E., Tirion, Felicia H., de Jong, Laurina A., Pols, Thijs W. H., Velden, Yme U. van der, Boorn, Jasper G. van den, Keller, Anna M., Buurman, Wim A., Theoret, Marc R., Blom, Bianca, Restifo, Nicholas P., Kruisbeek, Ada M., Kastelein, Robert A., Haanen, John B. A. G.
Format: Artigo
Jezik:Inglês
Izdano: 2006
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2242845/
https://ncbi.nlm.nih.gov/pubmed/16621986
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki